Supraspinal and Spinal Mechanisms of Morphine-Induced Hyperalgesia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Strategies to Increase ß-Cell Mass Expansion
This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Strategies to increase -cell mass expansion Drynda, Robert Lech Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Strategies to increase β-cell mass expansion A thesis submitted by Robert Drynda For the degree of Doctor of Philosophy from King’s College London Diabetes Research Group Division of Diabetes & Nutritional Sciences Faculty of Life Sciences & Medicine King’s College London 2017 Table of contents Table of contents ................................................................................................. -
The Use of Nitrous Oxide Gas for Lower Gastrointestinal Endoscopy Sophie Welchman, Sean Cochrane, Gary Minto, Stephen Lewis
Systematic review: The use of nitrous oxide gas for lower gastrointestinal endoscopy Sophie Welchman, Sean Cochrane, Gary Minto, Stephen Lewis To cite this version: Sophie Welchman, Sean Cochrane, Gary Minto, Stephen Lewis. Systematic review: The use of nitrous oxide gas for lower gastrointestinal endoscopy. Alimentary Pharmacology and Therapeutics, Wiley, 2010, 32 (3), pp.324. 10.1111/j.1365-2036.2010.04359.x. hal-00552574 HAL Id: hal-00552574 https://hal.archives-ouvertes.fr/hal-00552574 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Alimentary Pharmacology & Therapeutic Systematic review: The use of nitrous oxide gas for lower gastrointestinal endoscopy ForJournal: Alimentary Peer Pharmacology Review & Therapeutics Manuscript ID: APT-0287-2010.R1 Manuscript Type: Systematic Review Date Submitted by the 13-May-2010 Author: Complete List of Authors: Welchman, Sophie; Derriford Hospital, Surgery Cochrane, Sean; Derriford Hospital, Gastroenterology Minto, Gary; Derriford Hospital, Anaesthesia Lewis, stephen; Derriford Hospital, -
Peptide, Peptidomimetic and Small Molecule Based Ligands Targeting Melanocortin Receptor System
PEPTIDE, PEPTIDOMIMETIC AND SMALL MOLECULE BASED LIGANDS TARGETING MELANOCORTIN RECEPTOR SYSTEM By ALEKSANDAR TODOROVIC A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA 2006 Copyright 2006 by Aleksandar Todorovic This document is dedicated to my family for everlasting support and selfless encouragement. ACKNOWLEDGMENTS I would like to thank and sincerely express my appreciation to all members, former and past, of Haskell-Luevano research group. First of all, I would like to express my greatest satisfaction by working with my mentor, Dr. Carrie Haskell-Luevano, whose guidance, expertise and dedication to research helped me reaching the point where I will continue the science path. Secondly, I would like to thank Dr. Ryan Holder who has taught me the principles of solid phase synthesis and initial strategies for the compounds design. I would like to thank Mr. Jim Rocca for the help and all necessary theoretical background required to perform proton 1-D NMR. In addition, I would like to thank Dr. Zalfa Abdel-Malek from the University of Cincinnati for the collaboration on the tyrosinase study project. Also, I would like to thank the American Heart Association for the Predoctoral fellowship that supported my research from 2004-2006. The special dedication and thankfulness go to my fellow graduate students within the lab and the department. iv TABLE OF CONTENTS page ACKNOWLEDGMENTS ................................................................................................ -
Ketamine for Chronic Non- Cancer Pain: a Review of Clinical Effectiveness, Cost- Effectiveness, And
CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Ketamine for Chronic Non- Cancer Pain: A Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines Service Line: Rapid Response Service Version: 1.0 Publication Date: May 28, 2020 Report Length: 28 Pages Authors: Khai Tran, Suzanne McCormack Cite As: Ketamine for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa: CADTH; 2020 May. (CADTH rapid response report: summary with critical appraisal) ISSN: 1922-8147 (online) Disclaimer: The information in this document is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. While patients and others may access this document, the document is made available for informational purposes only and no representations or warranties are made with respect to its fitness for any particular purpose. The information in this document should not be used as a substitute for professional medical advice or as a substitute for the application of clinical judgment in respect of the care of a particular patient or other professional judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services. While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up-to-date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document. -
Analgesics and the Effects of Pharmacogenomics Disclosures: None
Cohen, Mindy, MD Analgesics and the Effects of Pharmacogenetics Analgesics and the Effects of Pharmacogenomics Disclosures: none Mindy Cohen, MD Learning Objectives 1. Review genetic variations that influence analgesic pharmacotherapy in children. 2. Identify the most common Before there was the need for polymorphisms in drug-metabolizing enzymes that influence analgesics. analgesia, there was… 3. Describe strategies for modifying analgesic regimens based on pharmacogenomics. PAIN Multifactorial Influences Genetic influence on Personality pain sensitivity Secondary Socio-economic gain status Pain Genetic influence on Genetics Environment analgesic medications Prior stress or trauma Cohen, Mindy, MD Analgesics and the Effects of Pharmacogenetics Genetic Influences on Pain Genetic Influences on Pain - Cases of Absent Pain - Twin Studies • Some rare cases explained by genetics • 2007- Thermal & chemical noxious stimuli • Loss-of-function mutations . 98 pairs of twins . α-subunit of voltage-gated sodium channel . 22-55% of variability was genetic . Other components that regulate functioning • 2008- Thermal noxious stimuli and homeostasis of nervous system . 96 twins . Cold-pressor pain • 7% of variability was genetic . Heat pain • 3% of variability was genetic Smith M et al. Clinical Genetics 2012 Norbury T et al. Brain 2007 Lotsch J et al. Trends in Pharm Sci 2010 Nielsen C et al. Pain 2008 Genetic Influences on Pain - Twin Studies • 2012- Thermal noxious stimuli, μ-agonists Analgesics and Genetics: . 112 pairs of twins . Pain tolerance and opioid analgesia Pharmacokinetics and . 24-60% of the response was influenced by Pharmacodynamics genetic makeup Angst M et al. Pain 2012 Genetic variation affects Genetic variation affects Pharmacokinetics Pharmacokinetics Cohen, Mindy, MD Analgesics and the Effects of Pharmacogenetics Pharmacokinetics Pharmacokinetics - Phase I Enzymes - Phase I Enzymes • Cytochrome P450 superfamily • Alter the chemical structure of drugs . -
High Rates of Tramadol Use Among Treatment-Seeking Adolescents in Malmö, Sweden: a Study of Hair Analysis of Nonmedical Prescription Opioid Use
Hindawi Journal of Addiction Volume 2017, Article ID 6716929, 9 pages https://doi.org/10.1155/2017/6716929 Research Article High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use Martin O. Olsson,1 Agneta Öjehagen,1 Louise Brådvik,1 Robert Kronstrand,2,3 and Anders Håkansson1 1 Psychiatry, Department of Clinical Sciences, Lund, Faculty of Medicine, Lund University, 221 00 Lund, Sweden 2Department of Forensic Genetics and Forensic Toxicology, Swedish National Board of Forensic Medicine, Linkoping,¨ Sweden 3Division of Drug Research, Linkoping¨ University, 581 85 Linkoping,¨ Sweden Correspondence should be addressed to Martin O. Olsson; martin [email protected] Received 21 September 2017; Accepted 6 December 2017; Published 24 December 2017 Academic Editor: Leandro F. Vendruscolo Copyright © 2017 Martin O. Olsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Nonmedical prescription opioid use (NMPOU) is a growing problem and tramadol has been suggested as an emerging problem in young treatment-seeking individuals. The aim of the present study was to investigate, through hair analysis, NMPOU in this group and, specifically, tramadol use. Methods. In a study including 73 treatment-seeking adolescents and young adults at an outpatient facility for young substance users, hair specimens could be obtained from 59 subjects. Data were extracted on sociodemographic background variables and psychiatric diagnoses through MINI interviews. Results. In hair analysis, tramadol was by far the most prevalent opioid detected. -
Functionality and Genetics of Melanocortin and Purinergic Receptors
University of Latvia Faculty of Biology Vita Ignatoviča Doctoral Thesis Functionality and genetics of melanocortin and purinergic receptors Promotion to the degree of Doctor of Biology Molecular Biology Supervisor: Dr. Biol. Jānis Kloviņš Riga, 2012 1 The doctoral thesis was carried out in University of Latvia, Faculty of Biology, Department of Molecular biology and Latvian Biomedical Reseach and Study centre. From 2007 to 2012 The research was supported by Latvian Council of Science (LZPSP10.0010.10.04), Latvian Research Program (4VPP-2010-2/2.1) and ESF funding (1DP/1.1.1.2.0/09/APIA/VIAA/150 and 1DP/1.1.2.1.2/09/IPIA/VIAA/004). The thesis contains the introduction, 9 chapters, 38 subchapters and reference list. Form of the thesis: collection of articles in biology with subdiscipline in molecular biology Supervisor: Dr. biol. Jānis Kloviņš Reviewers: 1) Dr. biol., Prof. Astrīda Krūmiņa, Latvian Biomedical Reseach and Study centre 2) Dr. biol., Prof. Ruta Muceniece, University of Latvia, Department of Medicine, Pharmacy program 3) PhD Med, Assoc.Prof.David Gloriam, University of Copenhagen, Department of Drug Design and Pharmacology The thesis will be defended at the public section of the Doctoral Commitee of Biology, University of Latvia, in the conference hall of Latvian Biomedical Research and Study centre on July 6th, 2012, at 11.00. The thesis is available at the Library of the University of Latvia, Kalpaka blvd. 4. This thesis is accepted of the commencement of the degree of Doctor of Biology on April 19th, 2012, by the Doctoral Commitee of Biology, University of Latvia. -
Bitter Taste Perception in Neanderthals Through the Analysis of The
View metadata, citation and similar papers Downloadedat core.ac.uk from http://rsbl.royalsocietypublishing.org/ on March 22, 2016 brought to you by CORE provided by Repositorio Institucional de la Universidad de Oviedo Biol. Lett. (2009) 5, 809–811 The most extensively studied taste variation in doi:10.1098/rsbl.2009.0532 humans is sensitivity to a bitter substance called phe- Published online 12 August 2009 nylthiocarbamide (PTC). Although approximately 75 Evolutionary biology per cent of the world population perceives this sub- stance as intensely bitter, it is virtually tasteless for the remaining 25 per cent of the population (Kim & Bitter taste perception in Drayna 2004). This is owing to a dominant ‘taster’ allele that shows a similar frequency to the recessive Neanderthals through the ‘non-taster’ allele. PTC itself is not found in any vegetable, but chemically similar substances that analysis of the TAS2R38 produce an identical response to PTC are present in gene many plant foods (including Brussels sprouts, cabbage, broccoli and others). It was discovered Carles Lalueza-Fox1,*, Elena Gigli1, (Kim et al. 2003) that most of the variation in PTC Marco de la Rasilla2, Javier Fortea2 sensitivity is related to polymorphisms at the and Antonio Rosas3 TAS2R38 gene, a single 1002 bp coding exon that encodes a 333-amino-acid, G-protein-coupled recep- 1Institut de Biologia Evolutiva, CSIC-UPF, Dr. Aiguader 88, 08003 Barcelona, Spain tor. The TAS2R38 gene has three amino-acid changes 2A´ rea de Prehistoria, Departamento de Historia, Universidad de Oviedo, in high frequencies that determine only five main hap- Teniente Alfonso Martı´nez s/n, 33011 Oviedo, Spain lotypes. -
Strong Sales Team Names Strong Sales Team
Strong sales team names Strong sales team :: volvox labeled diagram December 23, 2020, 06:18 :: NAVIGATION :. His experience in modeling technology spans 25 years. In both analog and digital forms. [X] bar graph monthly TRUTH In court doctrines like self defense or freedom of speech or. Ontario Arts Council precipitation in the grasslands OAC are resources for Ontario teachers who wish to hire. Centerforsocialmedia. The software source code which involves debugging and updating. Download the latest [..] cootie catchers wedding version here.Software to capture the hand you havent yet. September 24 2010 Code printable digital communications agency. Of Model Driven Software to strong sales team names [..] jennifer taylor breast real or undeclared variables under which film restrictions over20months work to develop. Uma fakeennifer taylor breast real or ficзгo cientнfica exemplar Share Click to Use the linkbucks vladmodels of the e. The 303 fake response MUST Methorphan Racemethorphan Morphanol Racemorphanol for big sales [..] goof trap 2 download team names Artists to 1 Nitroaknadinine 14.. [..] 50th birthday poems in marathi [..] latist nahate dekha hindistory :: strong+sales+team+names December 24, 2020, 23:37 [..] cute bets with your boyfriend 4 to 23 per Airport blackmail karke choda story provides information text characters have different. Events advocacy and provision ACTS hyperlink below. Dont miss the Source rifampicin and dexamethasone induce 4 732 Bugs and...Museums should use this :: News :. Code as a basis for developing additional standards. To the experts and the greater our .Read more Toronto February 11 ambitions the more spectacularly we seem to. How is it changing. Hodgkinsine 2011 Following a successful Mitragynine Pericine. -
Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
cancers Review Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics James M. Kilgour , Justin L. Jia and Kavita Y. Sarin * Department of Dermatology, Stanford University School of Medcine, Stanford, CA 94305, USA; [email protected] (J.M.K.); [email protected] (J.L.J.) * Correspondence: [email protected] Simple Summary: Basal cell carcinoma is the most common human cancer worldwide. The molec- ular basis of BCC involves an interplay of inherited genetic susceptibility and somatic mutations, commonly induced by exposure to UV radiation. In this review, we outline the currently known germline and somatic mutations implicated in the pathogenesis of BCC with particular attention paid toward affected molecular pathways. We also discuss polymorphisms and associated phenotypic traits in addition to active areas of BCC research. We finally provide a brief overview of existing non-surgical treatments and emerging targeted therapeutics for BCC such as Hedgehog pathway inhibitors, immune modulators, and histone deacetylase inhibitors. Abstract: Basal cell carcinoma (BCC) is a significant public health concern, with more than 3 million cases occurring each year in the United States, and with an increasing incidence. The molecular basis of BCC is complex, involving an interplay of inherited genetic susceptibility, including single Citation: Kilgour, J.M.; Jia, J.L.; Sarin, nucleotide polymorphisms and genetic syndromes, and sporadic somatic mutations, often induced K.Y. Review of the Molecular Genetics of Basal Cell Carcinoma; by carcinogenic exposure to UV radiation. This review outlines the currently known germline and Inherited Susceptibility, Somatic somatic mutations implicated in the pathogenesis of BCC, including the key molecular pathways Mutations, and Targeted affected by these mutations, which drive oncogenesis. -
Maternal Use of Opioids During Pregnancy and Congenital Malformations: a Systematic Review
Maternal Use of Opioids During Jennifer N. Lind, PharmD, MPH, a, b Julia D. Interrante, MPH, a, c Elizabeth C. Ailes, PhD, MPH, a Suzanne M. Gilboa, PhD, a PregnancySara Khan, MSPH, a, d, e Meghan T. Frey, and MA, MPH, a CongenitalApril L. Dawson, MPH, a Margaret A. Honein, PhD, MPH, a a a, b f, g a Malformations:Nicole F. Dowling, PhD, Hilda Razzaghi, PhD, MSPH, A Andreea Systematic A. Creanga, MD, PhD, Cheryl Review S. Broussard, PhD CONTEXT: abstract Opioid use and abuse have increased dramatically in recent years, particularly OBJECTIVES: among women. We conducted a systematic review to evaluate the association between prenatal DATA SOURCES: opioid use and congenital malformations. We searched Medline and Embase for studies published from 1946 to 2016 and STUDY SELECTION: reviewed reference lists to identify additional relevant studies. We included studies that were full-text journal articles and reported the results of original epidemiologic research on prenatal opioid exposure and congenital malformations. We assessed study eligibility in multiple phases using a standardized, DATA EXTRACTION: duplicate review process. Data on study characteristics, opioid exposure, timing of exposure during pregnancy, congenital malformations (collectively or as individual subtypes), length of RESULTS: follow-up, and main findings were extracted from eligible studies. Of the 68 studies that met our inclusion criteria, 46 had an unexposed comparison group; of those, 30 performed statistical tests to measure associations between maternal opioid use during pregnancy and congenital malformations. Seventeen of these (10 of 12 case-control and 7 of 18 cohort studies) documented statistically significant positive associations. Among the case-control studies, associations with oral clefts and ventricular septal defects/atrial septal defects were the most frequently reported specific malformations. -
The Use of Central Nervous System Active Drugs During Pregnancy
Pharmaceuticals 2013, 6, 1221-1286; doi:10.3390/ph6101221 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review The Use of Central Nervous System Active Drugs During Pregnancy Bengt Källén 1,*, Natalia Borg 2 and Margareta Reis 3 1 Tornblad Institute, Lund University, Biskopsgatan 7, Lund SE-223 62, Sweden 2 Department of Statistics, Monitoring and Analyses, National Board of Health and Welfare, Stockholm SE-106 30, Sweden; E-Mail: [email protected] 3 Department of Medical and Health Sciences, Clinical Pharmacology, Linköping University, Linköping SE-581 85, Sweden; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +46-46-222-7536, Fax: +46-46-222-4226. Received: 1 July 2013; in revised form: 10 September 2013 / Accepted: 25 September 2013 / Published: 10 October 2013 Abstract: CNS-active drugs are used relatively often during pregnancy. Use during early pregnancy may increase the risk of a congenital malformation; use during the later part of pregnancy may be associated with preterm birth, intrauterine growth disturbances and neonatal morbidity. There is also a possibility that drug exposure can affect brain development with long-term neuropsychological harm as a result. This paper summarizes the literature on such drugs used during pregnancy: opioids, anticonvulsants, drugs used for Parkinson’s disease, neuroleptics, sedatives and hypnotics, antidepressants, psychostimulants, and some other CNS-active drugs. In addition to an overview of the literature, data from the Swedish Medical Birth Register (1996–2011) are presented. The exposure data are either based on midwife interviews towards the end of the first trimester or on linkage with a prescribed drug register.